Drug
Acetaminophen
Acetaminophen: highest development phase Approved, developed by Fresenius Kabi, Hikma, Johnson & Johnson and others. 7 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Fresenius Kabi, Hikma, Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | Approved | |
| PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | Approved | |
| ROXICET | Approved | |
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Approved | |
| ACETAMINOPHEN | Approved | |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | Approved | |
| acetaminophen NCT00240773 | Phase 3 | Osteoarthritis, Hip |
Latest
Follow Acetaminophen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.